To our knowledge, this is the first time to integrate Mendelian randomization with GWAS and eQTL analyses, along with single-cell sequencing, to clarify the causal relationship between ARHGEF12 eQTL and chemoresistance in BLCA. This evidence concerns the gene ARHGEF12 and bladder transitional cell carcinoma.